Skip to main content
SpringerLink
Log in

VTE costs have large financial impact on EU healthcare systems

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 28 countries of the EU

  2. 2014 euros (adjusted for Purchasing Power Parity between countries)

  3. including premature death

Reference

  • Barco S, et al. European Union-28: An annualised cost-of-illness model for venous thromboembolism. Thrombosis and Haemostasis 115: No. 3, 26 Nov 2015. Available from: URL: http://doi.org/10.1160/TH15-08-0670

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

VTE costs have large financial impact on EU healthcare systems. PharmacoEcon Outcomes News 743, 32 (2015). https://doi.org/10.1007/s40274-015-2697-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2697-2

Search

Navigation